Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02897765
Title A Personalized Cancer Vaccine (NEO-PV-01) w/ Nivolumab for Patients With Melanoma, Lung Cancer or Bladder Cancer
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Neon Therapeutics, Inc.
Indications

bladder urothelial carcinoma

renal pelvis transitional cell carcinoma

ureter transitional cell carcinoma

melanoma

lung non-small cell carcinoma

urethra transitional cell carcinoma

Therapies

Nivolumab

NEO-PV-01 + Poly ICLC

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
City of Hope Duarte California 91010 United States Details
UCLA Medical Center Los Angeles California 90095 United States Details
University of California San Francisco San Francisco California 94143 United States Details
Massachusetts General Hospital Boston Massachusetts 02114 United States Details
Dana Farber Cancer Center Boston Massachusetts 02115 United States Details
Washington University in St. Louis Saint Louis Missouri 63130 United States Details
Icahn School of Medicine at Mount Sinai New York New York 10029 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
MD Anderson Cancer Center Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field